MYC Biyoteknoloji A.Ş.

MYC Biotechnology Inc. was established in Ankara in 2025 with the aim of developing domestic and innovative solutions in the field of genetic diagnosis. Our main area of activity is the production of FISH (Fluorescent In Situ Hybridization) probe kits for the detection of various genetic diseases, primarily hematological malignancies.

We base our product development process on the principles of scientific accuracy, high quality, and user-friendly design. All our production activities are carried out in accordance with the ISO 13485:2016 quality management system standard; our products are registered in the Product Tracking System (ÜTS) by the Turkish Medicines and Medical Devices Agency (TİTCK).

Our institution's primary motivation is to reduce Turkey's dependence on foreign sources in the field of molecular genetic diagnostics, to replace imported products with high-quality domestic alternatives, and to produce solutions that are highly competitive in the global market.

MYC Biotechnology is not just a manufacturer, but also a healthcare technology company that believes in scientific productivity, academic collaborations, and sustainable technology development. Our goal is to provide solutions that add value to both our country and the world, with an ethical, transparent, and continuously improving approach.